Last update 08 May 2025

PBPs x Serine protease x β-lactamase

Basic Info

Related Targets
PBPsSerine proteaseβ-lactamase

Related

1
Drugs associated with PBPs x Serine protease x β-lactamase
Xeruborbactam/Cefiderocol
Target
PBPs x Serine protease x β-lactamase
Mechanism
PBPs inhibitors [+2]
Active Org.
Shionogi & Co., Ltd.Shionogi & Co., Ltd.
Originator Org.
Shionogi & Co., Ltd.Shionogi & Co., Ltd.
Active Indication
Gram-Negative Bacterial Infections [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with PBPs x Serine protease x β-lactamase
NCT06547554
/ RecruitingPhase 1
A Phase 1, Randomized, Double-blind, Placebo-controlled, Drug-drug Interaction, Pharmacokinetic, and Safety Study of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants
100 Clinical Results associated with PBPs x Serine protease x β-lactamase
Login to view more data
100 Translational Medicine associated with PBPs x Serine protease x β-lactamase
Login to view more data
0 Patents (Medical) associated with PBPs x Serine protease x β-lactamase
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free